Below is an excerpt from the interview published in The Recorder on September 28, 2016.
Salima Merani, Ph.D. has been the lead intellectual property counsel on deals worth more than $2 billion in the last two years, including two recent deals worth $104 million and $64 million, for cutting-edge cancer immunotherapy and gene editing technologies. She was also lead counsel for a medtech company that was recently acquired for $600 million.
What’s your biggest pet peeve related to working in the tech sector?
Lawyers who think all tech deals are “one size fits all” and prepare contracts with pages of boilerplate language and mediocre strategy (if any). In my experience, tech deals can be very different, each benefiting from creativity, imagination and strategic insight.
Read the full interview below.
